Else Nutrition Holdings Inc. BABYF
0.03 USD 0.00 (+3.70%)
At closeNov 3, 2026, 4:00 PM EST
0.0286 Day range 0.0361
0.01 52-week range 0.374
- YTD
- -64.10%
- 1 year
- -74.55%
- Market cap
- 249.05K
- EPS (ttm)
- -0.88
- YTD return
- -64.10%
- 1-year return
- -74.55%
- Volume
- 83.26K
- Avg volume
- 71.48K
- Open
- 0.0361
- Previous close
- 0.027
- Day's range
- 0.0286 – 0.0361
- 52-week range
- 0.01 – 0.374
2Y -0.2230 (-89.20%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | 0.00 | -0.05 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | -0.01 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.03 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -0.03 | — | — |
| Nov 14, 2023 | Sep 1, 2023 | 0.00 | 0.01 | — | — |
| Aug 13, 2023 | Jun 1, 2023 | 0.00 | -0.02 | — | — |
News
Else Nutrn Hldg (OTCMKTS:BABYF) Stock Short Interest Drops 99.9% 
Else Nutrn Hldg (OTCMKTS:BABYF) Sees Significant Growth in Short Interest 
Else Nutrition Confirms Trading on a Post-Consolidation Basis 
Else Nutrition Announces CSE Listing and Consolidation 
Else Nutrition Announces CSE Conditional Approval 
Else Nutrition Commends Trump Administration's Expanded Commitment to Bolstering Infant Formulas Regulation in FY2027 
Else Nutrition Reports Fiscal Year 2025 Financial Results and Highlights Operational Progress, Strengthened Financial Foundation, and Clear Path Toward Profitability 
Else Nutrn (OTCMKTS:BABYF) vs. Medtronic (NYSE:MDT) Financial Survey 
Else Nutrition Expected to Benefit from FDA Regulatory Progress on Infant Formula Protein Standards 
Else Nutrition Surpasses One Million Cans Sold Since Launch
Your note
Sign in to keep a note on BABYF — it syncs with the Stock Master app.